Transaction · 0002043395-26-000012

Sayad Pierre Sargis

Sayad Pierre Sargis, CMO, reported an open-market or private sale at FENNEC PHARMACEUTICALS INC. involving 12000.000000 shares for an estimated $146160.00. Reported holdings after the transaction were 9519.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SCMO
FENCFENNEC PHARMACEUTICALS INC.
Trade date
Aug 31, 2026
Filing date
Sep 01, 2026
View on SEC Insider profile
Estimated value-$146kShares × reported price
Shares traded12.0k$12.18 per share
Holdings after9.51kDirect
% of reported position traded55.76%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 21,519 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

FENC price since this filing

Daily closing prices, with the filing date and available return windows
FENC · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -20.4%1w ago -5.2%1d ago -3.4%
Returns since7d +3.5%30d -11.5%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0002043395-26-000012
Common Shares
Transaction date
Aug 31, 2026
Filed Sep 01, 2026, 12:15 AM · 1d delay
Shares
12,000 sh
$12.18 per share
Estimated value
-$146k
Computed from shares × price
Holdings after
9,519 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Direct Ownership Large Holdings Reduction
Filing-only score

+10 points

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Medical Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Represents shares released from restriction from shares awarded 3/28/2025.

  2. F2

    Represents sale of previously vested restricted shares and vested performance shares.

Original filing · 0002043395-26-000012
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

FENC